Integral Health Asset Management’s Replimune Group REPL Stock Holding History

Integral Health Asset Management’s Portfolio REPL Stock Details REPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-250,000	Closed	-$4.28M	–	88
2023 Q3	$4.28M	Sell	250,000 -195,000	-44%	-$3.83M	0.59%	55
2023 Q2	$10.3M	Buy	445,000 +50,000	+13%	+$977K	1.28%	32
2023 Q1	$6.98M	Buy	395,000 +175,000	+80%	+$4.16M	1.41%	32
2022 Q4	$5.98M	Buy	220,000 +20,000	+10%	+$416K	1.26%	31
2022 Q3	$3.45M	Sell	200,000 -19,194	-9%	-$366K	0.67%	53
2022 Q2	$3.83M	Buy	219,194 +54,194	+33%	+$890K	0.79%	44
2022 Q1	$2.8M	Buy	165,000 +65,000	+65%	+$1.23M	0.73%	49
2021 Q4	$2.71M	Buy	100,000 +10,000	+11%	+$299K	0.75%	44
2021 Q3	$2.67M	Hold	90,000	–	–	0.77%	50
2021 Q2	$3.46M	Buy	90,000 +19,000	+27%	+$650K	0.95%	41
2021 Q1	$2.17M	Buy	71,000 +23,500	+49%	+$880K	0.62%	51
2020 Q4	$1.81M	Buy	+47,500	New	+$1.98M	0.54%	48

Other funds holding REPL

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Integral Health Asset Management's REPL Position: Q4 2023 in Review

Integral Health Asset Management sold out of Replimune Group (REPL) in Q4 2023, closing a stake of 250,000 shares — an estimated $4.28M sold.

Integral Health Asset Management first reported a position in REPL in Q4 2020 and held it in 12 quarters. The position peaked at $10.3M in Q2 2023. 140 funds tracked by Wall St. Rank hold REPL as of Q4 2023.

Integral Health Asset Management reported no remaining Replimune Group position as of Q4 2023 after selling out during the quarter.
Integral Health Asset Management sold 250,000 Replimune Group shares in Q4 2023, an estimated $4.28M.
Integral Health Asset Management first reported a position in Replimune Group in Q4 2020 and held it in 12 quarters.
Integral Health Asset Management's Replimune Group position peaked at $10.3M in Q2 2023.
140 funds tracked by Wall St. Rank held Replimune Group as of Q4 2023.

Based on Integral Health Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.